Durlaza
Product Images NDC 58487-001

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Durlaza (NDC 58487-001). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by New Haven Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

30 Count Label (Durlaza 30 Count Trade Label 19958 Nodie Sept 22 2015)

FDA Label Image

90 Count Label (Durlaza 90 Count Trade Label 19959 Nodie Sept 22 2015)

90 Count Label (Durlaza 90 Count Trade Label 19959 Nodie Sept 22 2015)
DURLAZA is an aspirin product, manufactured in the USA by New Haven Pharmaceuticals, Inc. Each capsule contains 162.5 g of aspirin and is meant to be swallowed whole for extended release. The recommended dosage is one capsule per day. DURLAZA comes in a package of 90 capsules, and detailed prescribing information is available in the package insert. It should be stored between 15-30°C and kept out of reach of children. More information is available at durlaza.com.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
This is a graphical representation of the mean acetylsalicylic acid concentration over time after administering a single dose of 162.5 mg DURLAZA or 81 mg immediate-release ASA. The data is presented for 18 individuals in each group. Therefore, it is not possible to extract any further information without additional data or context.*
FDA Label Image

Structural Formula (Structural Formula)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.